In an unprecedented move, Atai Life Sciences, a global biotech company, has invested a significant amount in Beckley Psytech, a company specializing in psychedelic medicine. This strategic investment marks a monumental step towards the development of rapid-acting psychedelic medicines, signifying a potential paradigm shift in mental health treatment.

Esketamine nasal spray presents a promising new frontier in the battle against treatment-resistant depression. While further research is warranted, the current findings offer hope to those seeking effective and rapid relief from the debilitating effects of depression. The K-hole phenomenon illuminates the precarious balance between the quest for altered states of consciousness and the stark reality of potential harm. Despite the risks, the allure of the K-hole continues to captivate some, showcasing the complex and sometimes dangerous relationship individuals share with substances like ketamine.

Living underwater for 100 days may sound like a fantasy, but for Dr. Deep, it was a reality. Dr. Deep, a renowned marine biologist and explorer, spent 100 days in a specially designed habitat at the bottom of the Atlantic Ocean, conducting research on the effects of deep-sea living on the human body and mind.

Enthea, a provider of psychedelic healthcare insurance plans, declared that it will expand its services into 40 markets across the US in 2023 with the goal of making workplace benefits for psychedelic-assisted therapies reasonable, equitable, and available.

A Maryland House of Delegates Committee recently held a hearing on creating a psychedelics access fund. The Post-Traumatic Stress Disorder and Traumatic Brain Injury Alternative Therapies Fund could give Maryland’s veterans access to psychedelics like psilocybin, MDMA, and ketamine to help them find relief.

A Florida bill would legalize magic mushrooms and give patients safe access to psychedelics for psychedelic assisted psychotherapy. The bill was introduced after similar initiatives in Oregon and Washington D.C. were passed in 2020. Grieco was proposing legal access as well as consumption of psilocybin mushrooms. In Florida, access will be limited to people with a diagnosis of a mental health condition. That would mean limited legal access to mushrooms for psychedelic assisted psychotherapy for military veterans with PTSD and terminally ill patients.